Using Biologics to Reduce Long‐Term Corticosteroid Use in Pyoderma Gangrenosum: Real‐World Evidence From Two Centres
While corticosteroids provide an initial advantage, biologics demonstrate gradual and sustained efficacy, suggesting a long-term therapeutic role in PG treatment.
Authors
- Dedee Frances Murrell (ORCID: https://orcid.org/0000-0003-2971-0199)
- Michael Stark (ORCID: https://orcid.org/0000-0002-1481-9506)
- Luigi Gargiulo (ORCID: https://orcid.org/0000-0002-6051-1676)
- Ruggero Cascio Ingurgio (ORCID: https://orcid.org/0009-0000-1438-9553)
- Antonio Costanzo (ORCID: https://orcid.org/0000-0001-9697-2557)
- Alessandra Alfano (ORCID: https://orcid.org/0009-0004-6269-448X)
- Luciano Ibba (ORCID: https://orcid.org/0000-0002-7876-4866)
- Fanny Satgé (ORCID: https://orcid.org/0000-0002-5849-3421)
- Alessandra Narcisi (ORCID: https://orcid.org/0000-0002-1938-8581)
Institutions
- Humanitas University (IT)
- UNSW Sydney (AU)
- Centre Hospitalier Universitaire de La Réunion (RE)
- St George Hospital (AU)
- IRCCS Humanitas Research Hospital (IT)
Publication Details
- Journal
- Australasian Journal of Dermatology
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1111/ajd.14532
- Citations
- 1
- Primary Topic
- Autoimmune and Inflammatory Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.35